His primary areas of investigation include Internal medicine, Surgery, Risk factor, Cancer and Relative risk. His research brings together the fields of Gastroenterology and Internal medicine. His Surgery research is multidisciplinary, incorporating perspectives in Colorectal adenoma, Hip fracture, Epidemiology and Confidence interval.
His Risk factor research is multidisciplinary, incorporating elements of Odds ratio, Case-control study, Gynecology, Ovarian cancer and Breast cancer. His work deals with themes such as Prospective cohort study, Disease and Cohort study, which intersect with Cancer. His studies deal with areas such as Pulmonary embolism and Venous thrombosis as well as Relative risk.
John A. Baron mainly investigates Internal medicine, Colorectal cancer, Cancer, Gastroenterology and Surgery. His Internal medicine research integrates issues from Endocrinology and Oncology. His work carried out in the field of Colorectal cancer brings together such families of science as Microsatellite instability, Prospective cohort study, Pathology and Single-nucleotide polymorphism, Genotype.
John A. Baron has researched Gastroenterology in several fields, including Calcium, Randomized controlled trial, Colonoscopy, Colorectal adenoma and Aspirin. His Surgery study combines topics from a wide range of disciplines, such as Hip fracture, Epidemiology, Incidence, Cohort study and Hazard ratio. Within one scientific family, John A. Baron focuses on topics pertaining to Breast cancer under Odds ratio, and may sometimes address concerns connected to Gynecology.
His scientific interests lie mostly in Internal medicine, Colorectal cancer, Gastroenterology, Oncology and Cancer. Adenoma, Odds ratio, Vitamin D and neurology, Colonoscopy and Randomized controlled trial are the subjects of his Internal medicine studies. His Odds ratio study integrates concerns from other disciplines, such as Case-control study and Risk factor.
His Colorectal cancer study combines topics in areas such as Surgery, Incidence, Bioinformatics, Microsatellite instability and Confidence interval. His Gastroenterology research is multidisciplinary, relying on both Clinical trial, Absolute risk reduction, Eosinophilic esophagitis, Colorectal adenoma and Aspirin. His Cancer research incorporates themes from Cancer research and Hazard ratio.
John A. Baron mostly deals with Internal medicine, Colorectal cancer, Gastroenterology, Odds ratio and Colonoscopy. Much of his study explores Internal medicine relationship to Oncology. The Colorectal cancer study combines topics in areas such as Proportional hazards model, Surgery, Cohort study, Incidence and Young adult.
His Gastroenterology study incorporates themes from Pregnancy, Randomized controlled trial and Screening colonoscopy. His research in Odds ratio intersects with topics in Case-control study and Risk factor. His research investigates the link between Colonoscopy and topics such as Dysplasia that cross with problems in Colorectal Polyp and Splenic flexure.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
Robert S. Bresalier;Robert S. Sandler;Hui Quan;James A. Bolognese.
The New England Journal of Medicine (2005)
Tobacco smoke and involuntary smoking
Michael Alavanja;John A. Baron;Ross C. Brownson;Patricia A. Buffler.
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (2004)
A randomized trial of aspirin to prevent colorectal adenomas
John A. Baron;Bernard F. Cole;Robert S. Sandler;Robert W. Haile.
The New England Journal of Medicine (2003)
Prognosis of cancers associated with venous thromboembolism.
H. Sorensen;L. Mellemkjaer;J. Olsen;J. Baron.
The New England Journal of Medicine (2000)
Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis
Mark J Bolland;Alison Avenell;John A Baron;Andrew Grey.
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
Robert S. Sandler;Susan Halabi;John A. Baron;Susan Budinger.
The New England Journal of Medicine (2003)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials
Colin Baigent;N. Bhala;J. Emberson;A. Merhi.
The Lancet (2013)
Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel
Douglas K. Rex;Dennis J. Ahnen;John A. Baron;Kenneth P. Batts.
The American Journal of Gastroenterology (2012)
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
Bernard F. Cole;John A. Baron;Robert S. Sandler;Robert W. Haile.
Calcium Supplements for the Prevention of Colorectal Adenomas
Baron Ja;Beach M;Beach M;Mandel Js;van Stolk Ru.
The New England Journal of Medicine (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: